Assessing and Improving the
Biocompatibility and Usability of
Composite, Additively
Manufactured Organ-On-Chip
Devices

Objectives
1: Development of a live/dead cell viability assay
• Custom suited to non-destructive time course analysis
• TIME-GFP

2: Enhance the biocompatibility of composite devices through surface
coating with bioactive molecules and electrical surface treatment
• Bioactive Molecule: Poly-D-Lysine (PDL), Poly-norepinephrine (PNE), Polydopamine (PDA)
• Electrical Surface Treatment: Corona Treatment
• Live dead results

Fluidic Organ-on-Chip (OOC):
• In vitro micro-physiological system:
simulates complex in vivo biological
activities
• Microfluidic chip: a set of connected microchannels molded or engraved within specific
material.
• Allows for the set-up, control, and
monitoring of different parameters under
various biological scenarios.
• Disease modelling, Drug development,
Toxicity assessment

• By more closely mimicing in vivo conditions
is better predictor than standard, static in
vitro cell culture models.
• By using human cells it can be a better
predictor than animal models

Microfluidic chip model for lung-on-a-chip doi: https://doi.org/10.1038/nprot.2013.137

Problem Statement
• Current methods of manufacturing fluidic OOC devices require advanced
skill set and significant time to fabricate
• Photolithography, soft-lithography, multi-layer alignment
• Requires multiple steps and high-skill human assembly
• Increases time and cost of fabrication
• Decreases yield (high failure rate)

• Additive manufacturing, specifically fused filament
fabrication can address these issues
•

Inherent in the 3D printing is automation of alignment

Principle of FFF printing DOI:10.24867/GRID-2018-p28

Overall goal of the work:
• Develop affordable, biocompatible, 3D printed organ-on-chip (OOC)
systems.

Assessing the biocompatibility of 3D printed
cell culture devices
• New materials and processes MUST be biocompatible.
• Cytotoxicity - In vitro material biocompatibility indicator
• Defined as substances’ ability to damage cell membrane integrity or cell DNA,
causing cell death.

• We wanted to be able to monitor cell viability (the ratio of healthy live
cells to apoptotic (dying) cells) in a non-destructive assay.

Development of live/dead cell
viability assay

Live/Dead Cell Viability Assay using Fluorescent
Dyes
• Calcein Blue AM/7-AAD
• Calcein Blue AM (CB): hydrolyzed
by intracellular esterase in live cells
to fluorescent
• 7-AAD: enter the damaged
membrane of dead/apoptotic cells
and binds to GC region of the DNA,
detect different stages of apoptotic
cells by signal intensity, and the
fluorescent last 4 hours.

• TIME-GFP (ATCC CRL-4045)
• Telomerase Immortalized Microvascular
Endothelial cells
• express Green Fluorescent Protein
• Transfecting TIME (ATCC CRL-4025) cells with
the pWE2-EmGFP plasmids
GFP

Calcein AM

GFP: https://www.olympus-lifescience.com/en/microscope-resource/primer/techniques/confocal/applications/gfpintro/
Calcein AM: https://biotium.com/product/calcein-am-cell-viability-assay-kit/

Optimize Protocol
• Temperature
• Storage
• Rinsing
• Incubation Time

Incubation temperature

CB+7AAD incubated at 37ºC

CB+7AAD at 25ºC
GFP expressed by live cells

CB incubated at 37ºC
7AAD incubated on ice

• Calcein Blue AM best incubate at 37 degrees and 7AAD best incubate on ice

Calcein Blue AM Working Solution Shelf-Life

CB Stored in 4 degrees for more than 2 days

CB stored in -20 degrees, thawed before use

• Calcein Blue AM (CB) need to be aliquoted into smaller value and store in -20 degrees,
thaw every time before use.

Washing is necessaryà7AAD

GFP (Live Cells)

7AAD + Lack of washing à Cell Death☠

• 7AAD is relative cytotoxic and need to be removed and washed by PBS
before observation

Incubation Time
10mins incubation

• 10mins are too short:
• Calcein Blue AMàWeak signal
• 7AADàNo Signal (Background Noise)
• 30mins incubation time of 7AAD (on ice) decrease cell
viability

15mins incubation

• 15mins incubation time work the best for both Calcein
Blue AM and 7AAD

Calcein Blue AM (Live)
7-AAD (Dead)
30mins incubation
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Biocompatibility of cells on unmodified Cyclic
Olefin Copolymer (COC)
• Used in medical devices
• Vials, lens, bottles, packaging

• Thermoplastic material
• Advantageous properties for LOC and OOC devices
•
•
•
•
•

High chemical resistance
Biologically inertness
Low water absorption
Low oxygen permeability
Excellent optical transparency
• 300nm – 700 nm

Biocompatibility of cells on unmodified COC
• Disadvantages
• Low DTUL
• Can only withstand short
(5min) autoclaving
• Hydrophobic material
• Prevents cell adhesion,
decreased cell viability

3D-printed COC 24 well cell culture plate

Improving biocompatibility of composite devices
through surface coating with bioactive molecules
and electrical surface treatment
Objective 2

Enhancing biocompatibility with biomolecules
• PDA (Poly-dopamine)
• Catecholamine polymers inspired by mussels
• Self-polymerize on wide range of hydrophobic material surfaces
• Precipitate and produce dark aggregates (Oligo-DA-particles) and
generate rough surfaces

A

• PNE (Poly-norepinephrine)
• Closely related to PDA with ability to self-polymerize
• Produce less aggregates and generate smoother surfaces
• Higher wettability, implied by smaller WCA

B

C

• Both PDA and PNE is autoclavable.
• Methods
• PDL (1mg/mL), PNE (0.5mg/mL), PDA (1mg/mL)
• Surface coating time: 1hr, 2hr, overnight
• 3X Rinsing with PBS for 10 mins
• Control: Commercial TCP(Positive) & COC(Negative)
Tan, X; Bioact. Mater. 2021, 6 (1), 285–296. https://doi.org/10.1016/j.bioactmat.2020.06.024.
Khetani, S; ACS Appl. Mater. Interfaces 2020, 12 (6), 6910–6923. https://doi.org/10.1021/acsami.9b20826.

PDA and PNE:
A) Molecular structure and prepared PDA, and PNE solution after 1 min, 6 hrs,
24 hrs ,
B) aggregates formed by PNE and PDA,
C) water contact angle (WCA) of PDA and PNE
https://doi.org/10.1016/j.bioactmat.2020.06.024.

Unmodified Surface Controls
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Cells were counted via ImageJ
PDA 1hr has the most live cells and highest viability!

Surface Modification
Aggregation under Bright Field
• Rinsing is necessary and critical
to remove excess molecules
• PDL and PNE does not improve
cell adhesion on COC
• PDA 1hr incubation showed
highest and equivalent viability
compare to commercial TCP.
Also, less aggregates compare
to overnight incubation.
PDA 1hr Incubation

PDA Overnight Incubation (Aggregation)

Corona treatment-Current
• Similar to oxygen plasma treatment,
but with lower plasma density

A

• Relies on free ambient air, smaller
size, less expensive
• Decreased COC water contact angle
with pre-experiment.
• Compare surface modification (PDA,
PNE) with and without Corona
Treatment as well as Corona
Treatment only

B

• Conditions: Treatment time, voltage,
height between device surface and
corona treater, and etc.
A) Mechanisms of gas plasma treatment, B) Conventional corona treater

Future Work
• Compare the biocompatibility of corona-treated devices with
commercial TCPs
•
•
•
•

Contact Angle
Morphology
Proliferation
Live/Dead

• Apply developed techniques to devices with additional components
from silicone and chitosan

Conclusion
• Established and optimized a dual-staining protocol for a live/dead cell viability assay
using Calcein Blue AM and 7-AAD
• Applied viability assay to analyze the biocompatibility of various materials
• Cyclic Olefin Copolymer (COC) in the form of 3D-printed COC cell culture plates using fused
filament fabrication (FFF) technique
• Surface modified COC devices
• COC devices with additional materials including chitosan and silicon (Next Step!)

• Significance:
• Set the foundation for future research to fabricate functional organ-on-chip (OOC) systems on a
manufacturing level with COC by 3D FFF-bioprinting.
• Ultimately promote OOC applications from research base to clinical based
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